Ovid Therapeutics (OVID) Enterprise Value Growth (3y) (2019 - 2026)
Ovid Therapeutics (OVID) Enterprise Value Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Ovid Therapeutics | 118.66 Mn | -36.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.73% |
| Dec 31, 2025 | 17.97% |
| Sep 30, 2025 | 43.04% |
| Jun 30, 2025 | 36.86% |
| Mar 31, 2025 | 37.69% |
| Dec 31, 2024 | 34.59% |
| Sep 30, 2024 | 32.91% |
| Jun 30, 2024 | 28.68% |
| Mar 31, 2024 | 27.47% |
| Dec 31, 2023 | -12.71% |
| Sep 30, 2023 | -0.08% |
| Jun 30, 2023 | -32.75% |
| Mar 31, 2023 | -26.37% |
| Dec 31, 2022 | -18.02% |
| Sep 30, 2022 | -53.78% |
| Jun 30, 2022 | -47.62% |
| Mar 31, 2022 | -41.40% |
| Dec 31, 2021 | -65.40% |
| Sep 30, 2021 | -56.64% |
| Jun 30, 2021 | -50.22% |